Institute for Clinical Chemistry and Laboratory Medicine, University of Greifswald, Ferdinand-Sauerbruch Str, Greifswald 17475, Germany.
BMC Med Res Methodol. 2011 Jul 12;11:103. doi: 10.1186/1471-2288-11-103.
Associations between measures of subjective health and mortality risk have previously been shown. We assessed the impact and comparative predictive performance of a multi-biomarker panel on this association.
Data from 4,261 individuals aged 20-79 years recruited for the population-based Study of Health in Pomerania was used. During an average 9.7 year follow-up, 456 deaths (10.7%) occurred. Subjective health was assessed by SF-12 derived physical (PCS-12) and mental component summaries (MCS-12), and a single-item self-rated health (SRH) question. We implemented Cox proportional-hazards regression models to investigate the association of subjective health with mortality and to assess the impact of a combination of 10 biomarkers on this association. Variable selection procedures were used to identify a parsimonious set of subjective health measures and biomarkers, whose predictive ability was compared using receiver operating characteristic (ROC) curves, C-statistics, and reclassification methods.
In age- and gender-adjusted Cox models, poor SRH (hazard ratio (HR), 2.07; 95% CI, 1.34-3.20) and low PCS-12 scores (lowest vs. highest quartile: HR, 1.75; 95% CI, 1.31-2.33) were significantly associated with increased risk of all-cause mortality; an association independent of various covariates and biomarkers. Furthermore, selected subjective health measures yielded a significantly higher C-statistic (0.883) compared to the selected biomarker panel (0.872), whereas a combined assessment showed the highest C-statistic (0.887) with a highly significant integrated discrimination improvement of 1.5% (p < 0.01).
Adding biomarker information did not affect the association of subjective health measures with mortality, but significantly improved risk stratification. Thus, a combined assessment of self-reported subjective health and measured biomarkers may be useful to identify high-risk individuals for intensified monitoring.
先前已经证明,主观健康指标与死亡风险之间存在关联。我们评估了多生物标志物组对这种关联的影响和比较预测性能。
使用了年龄在 20-79 岁之间的 4261 名参加波美拉尼亚人群健康研究的个体的数据。在平均 9.7 年的随访期间,发生了 456 例死亡(10.7%)。主观健康通过 SF-12 衍生的身体成分综合评分(PCS-12)和心理成分综合评分(MCS-12)以及单项自我报告健康(SRH)问题进行评估。我们实施了 Cox 比例风险回归模型来研究主观健康与死亡率之间的关联,并评估了 10 种生物标志物组合对这种关联的影响。使用变量选择程序来识别一组简洁的主观健康测量和生物标志物,使用接收者操作特征(ROC)曲线、C 统计量和重新分类方法比较其预测能力。
在年龄和性别调整的 Cox 模型中,不良的 SRH(危险比(HR),2.07;95%置信区间,1.34-3.20)和低 PCS-12 评分(最低与最高四分位数:HR,1.75;95%置信区间,1.31-2.33)与全因死亡率增加显著相关;这种关联独立于各种协变量和生物标志物。此外,选择的主观健康测量得出的 C 统计量(0.883)显著高于所选生物标志物组(0.872),而联合评估显示出最高的 C 统计量(0.887),具有显著提高 1.5%(p < 0.01)的综合判别改善。
添加生物标志物信息不会影响主观健康指标与死亡率之间的关联,但可显著改善风险分层。因此,自我报告的主观健康和测量的生物标志物的综合评估可能有助于识别需要强化监测的高危个体。